Fresenius SE Revenue 2016-2024 | FSNUY

Fresenius SE annual/quarterly revenue history and growth rate from 2016 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Fresenius SE revenue for the quarter ending June 30, 2024 was $5.880B, a 47.94% decline year-over-year.
  • Fresenius SE revenue for the twelve months ending June 30, 2024 was $13.936B, a 68.13% decline year-over-year.
  • Fresenius SE annual revenue for 2023 was $24.134B, a 43.91% decline from 2022.
  • Fresenius SE annual revenue for 2022 was $43.029B, a 3.07% decline from 2021.
  • Fresenius SE annual revenue for 2021 was $44.39B, a 7.12% increase from 2020.
Fresenius SE Annual Revenue
(Millions of US $)
2023 $24,134
2022 $43,029
2021 $44,390
2020 $41,439
2019 $39,658
2018 $39,599
2017 $38,301
2016 $32,183
2015 $30,676
Fresenius SE Quarterly Revenue
(Millions of US $)
2024-06-30 $5,880
2024-03-31 $6,193
2023-12-31 $-4,143
2023-09-30 $6,006
2023-06-30 $11,295
2023-03-31 $10,976
2022-12-31 $10,926
2022-09-30 $10,534
2022-06-30 $10,661
2022-03-31 $10,908
2021-12-31 $11,423
2021-09-30 $10,995
2021-06-30 $11,141
2021-03-31 $10,831
2020-12-31 $11,115
2020-09-30 $10,425
2020-06-30 $9,822
2020-03-31 $10,078
2019-12-31 $10,330
2019-09-30 $9,832
2019-06-30 $9,847
2019-03-31 $9,649
2018-12-31 $10,095
2018-09-30 $9,525
2018-06-30 $9,996
2018-03-31 $9,982
2017-12-31 $10,254
2017-09-30 $9,751
2017-06-30 $9,384
2017-03-31 $8,911
2016-12-31 $8,423
2016-09-30 $8,121
2016-06-30 $8,011
2016-03-31 $7,628
2015-12-31 $7,951
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.921B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00